Actuate Therapeutics ACTU
NASDAQ ACTU
$0.87 +0.09 (+11.58%)
As of: Oct 1, 2026 · 2:06 PM EDT

Actuate Therapeutics (ACTU) Non Operating Income (2023 - 2026)

Updated

Actuate Therapeutics' Non Operating Income was $39,953 in Q2 2026, up 105.2% from $19,472 a year earlier.

Analysis

Actuate Therapeutics (ACTU) Non Operating Income (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Actuate Therapeutics' Non Operating Income was $258,853 through Jun 30, 2026; for FY2025, it was $267,460.

  • In earlier years, Non Operating Income was -$2.12 million in FY2024 and $229,209 in FY2023.
  • Quarterly Non Operating Income has moved between -$1.14 million (Q2 2024) and $137,748 (Q3 2023) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Actuate Therapeutics 18.73 Mn 18.73 Mn - 39,953.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39,953.00
Dec 31, 2025 134,520.00
Sep 30, 2025 64,908.00
Jun 30, 2025 19,472.00
Mar 31, 2025 48,560.00
Dec 31, 2024 113,039.00
Sep 30, 2024 -578,058.00
Jun 30, 2024 -1.14 Mn
Mar 31, 2024 -522,805.00
Dec 31, 2023 3,027.00
Sep 30, 2023 137,748.00
Jun 30, 2023 60,133.00
API Access

Actuate Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ACTU&period=max&api_key=YOUR_API_KEY